Literature DB >> 25236874

Incidence, trends, and predictors of ischemic stroke 1 year after an acute myocardial infarction.

Anders Ulvenstam1, Ulf Kajermo2, Angelo Modica2, Tomas Jernberg2, Lars Söderström2, Thomas Mooe2.   

Abstract

BACKGROUND AND
PURPOSE: Ischemic stroke after acute myocardial infarction is an important complication. It is unknown whether the risk has changed because the treatment of acute myocardial infarction has improved during the past decade. There is also conflicting data about predictors of stroke risk.
METHODS: To obtain the 1-year incidence of stroke after acute myocardial infarction, the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions database for the years 1998 to 2008 was merged with the Swedish National Patient Register (NPR). The time trend was studied by dividing the entire time period into 5 separate periods. Independent predictors were identified using a multivariable Cox proportional hazards regression model.
RESULTS: Between 1998 and 2008, 7185 of 173 233 patients with acute myocardial infarction had an ischemic stroke within 1 year (4.1%). There was a 20% relative risk reduction during the study period (1998-2000 versus 2007-2008) relative risk 0.80 (95% confidence interval, 0.75-0.86; P<0.001. Independent predictors of stroke were age, female sex, ST-segment-elevation myocardial infarction, previous stroke, previous diabetes mellitus, heart failure at admission, angiotensin-converting enzyme inhibitor treatment and atrial fibrillation. Reperfusion treatment with fibrinolysis and percutaneous coronary intervention and treatment with aspirin, P2Y12-inhibitors, and statins predicted a reduced risk of stroke.
CONCLUSIONS: The risk of ischemic stroke within a year after myocardial infarction is substantial but has clearly been reduced during the studied time period. The major predictive factors found to correlate well with previous investigations. Reperfusion treatment, thrombocyte aggregation inhibition, and lipid lowering are the main contributors to the observed risk reduction.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  cerebral infarction; epidemiology; risk factors

Mesh:

Year:  2014        PMID: 25236874     DOI: 10.1161/STROKEAHA.114.005770

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  12 in total

Review 1.  Management of Oral Anticoagulation and Antiplatelet Therapy in Post-Myocardial Infarction Patients with Acute Ischemic Stroke with and without Atrial Fibrillation.

Authors:  Francesca Romana Pezzella; Marilena Mangiardi; Mario Ferrante; Sebastiano Fabiano; Sabrina Anticoli; Fabrizio Giorgio Pennacchi; Antonella Urso; Leonardo De Luca; Valeria Caso
Journal:  J Clin Med       Date:  2022-07-04       Impact factor: 4.964

2.  Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study.

Authors:  Stina Jakobsson; Anna-Lotta Irewall; Fredrik Bjorklund; Thomas Mooe
Journal:  BMC Cardiovasc Disord       Date:  2015-10-14       Impact factor: 2.298

3.  Ischemic Stroke Risk After Acute Coronary Syndrome.

Authors:  Shadi Yaghi; Markeith Pilot; Christopher Song; Christina A Blum; Aleksandra Yakhkind; Brian Silver; Karen L Furie; Mitchell S V Elkind; Dean Sherzai; Ayesha Z Sherzai
Journal:  J Am Heart Assoc       Date:  2016-07-13       Impact factor: 5.501

4.  Influence of interleukin-1β gene polymorphism on the risk of myocardial infarction complicated with ischemic stroke.

Authors:  Lei Chen; Feng Lu; Zhan Wang; Liwei Liu; Lizhi Yin; Jing Zhang; Qiang Meng
Journal:  Exp Ther Med       Date:  2018-10-09       Impact factor: 2.447

5.  Risk of Ischemic Stroke After Acute Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery.

Authors:  André Åström; Lars Söderström; Thomas Mooe
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

6.  In-Hospital acute ischemic stroke following ST-elevation myocardial infarction.

Authors:  Aiham Albaeni; Ché Matthew Harris; Hesham Nasser; Sirhley Sifontes; S Mustajab Hasan; Sai Guduru; Khalid Abusaada; Khaled Chatila; Syed Gilani; Wissam I Khalife
Journal:  Int J Cardiol Heart Vasc       Date:  2020-12-10

7.  Temporal Trends, Predictors, and Outcomes of Acute Ischemic Stroke in Acute Myocardial Infarction in the United States.

Authors:  Gaurav Aggarwal; Sri Harsha Patlolla; Saurabh Aggarwal; Wisit Cheungpasitporn; Rajkumar Doshi; Pranathi R Sundaragiri; Alejandro A Rabinstein; Allan S Jaffe; Gregory W Barsness; Marc Cohen; Saraschandra Vallabhajosyula
Journal:  J Am Heart Assoc       Date:  2021-01-05       Impact factor: 5.501

8.  Efficacy and safety of ticagrelor versus clopidogrel in patients with non-ST-elevation myocardial infarction in Taiwan.

Authors:  Chih-Kuo Lee; Tzung-Dau Wang; Hsiao-Ting Juang; Shu-Chen Chang; Heng-Yu Pan; Donna Shu-Han Lin; Chee-Jen Chang
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

9.  The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction.

Authors:  Robin Henriksson; Fredrik Björklund; Thomas Mooe
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

10.  Increase in ticagrelor use over time is associated with lower rates of ischemic stroke following myocardial infarction.

Authors:  Robin Henriksson; Anders Ulvenstam; Lars Söderström; Thomas Mooe
Journal:  BMC Cardiovasc Disord       Date:  2019-03-04       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.